MAP — Microba Life Sciences Share News
0.000.00%
- AU$24.16m
- AU$20.32m
- AU$14.76m
Australia's Microba Life Sciences falls as annual loss widens
Brief: Microba Life Sciences Says Loss For Year Attributable A$19.9 Million
Brief: Microba Life Sciences Posts A$4.81 Mln Q4 Fy24 Unaudited Revenue
Australia's Microba Life Sciences gains most in two weeks on Q3 results
Brief: Microba Life Sciences Says A$4.00M In Q3 FY24 Unaudited Revenue
Brief: Microba Life Sciences Posts H1 Revenue Result Of A$3.27M
Brief: Microba Life Sciences Says 1H Unaudited Revenue Totalled A$3.27M
Brief: Microba Life Sciences Says Research Agreement Executed With IFF
Australia's Microba Life Sciences faces worst day ever on discounted placement
Brief: Microba Life Sciences Says Fully Underwritten A$20 Million Entitlement Offer
Brief: Microba Life Sciences To Acquire Invivo Clinical
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Says Loss For Year Attributable A$12.7 Mln
Brief: Microba Life Sciences Says Q4 FY23 Unaudited Revenue Totalled A$2.25M
Brief: Microba Life Sciences Executes First Distribution Agreement With Sonic Healthcare
Australia's Microba Life Sciences jumps on distribution deal with Sonic Healthcare
Brief: Microba Life Sciences Sats MRRF Awarded A$2.92M Grant To Queensland University Of Technology
Brief: Microba PTY Says Q3 Unaudited Revenue Totalled A$1.01M
Australia's Microba rises on agreements with SYNLAB for European expansion